NAVB
Navidea Biopharmaceuticals, Inc
NYSE MKT
People also watch:IMUCGALECLSNCPRXZGNX
0.520.00 (0.38%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close0.52
Open0.54
Bid0.52 x 1300
Ask0.52 x 2600
52wk Range0.47 - 2.50
Day's Range0.51 - 0.54
Volume324,567
Avg Vol (3m)1,084,344
As of 4:02 PM EDT. Market closed.
  • Capital Cube5 days ago

    ETF’s with exposure to Navidea Biopharmaceuticals, Inc. : July 20, 2016

    Click here to see latest analysis*Disclaimer : This is as of previous day’s closeETF’s with exposure to Navidea Biopharmaceuticals, Inc.Here are 5 ETF’s with the largest exposure to NAVB-US. Comparing the performance and risk of Navidea Biopharmaceuticals, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us […] (Read more...) The post ETF’s with exposure to Navidea Biopharmaceuticals, Inc. : July 20, 2016 appeared first on CapitalCube.

  • Platinum Partners to Shut Down Main Fund; Here Are Its 5 Stock Picks
    Insider Monkey20 days ago

    Platinum Partners to Shut Down Main Fund; Here Are Its 5 Stock Picks

    Platinum Partners, the New York-based hedge fund that is in the midst of two investigations, recently informed its investors that it will be liquidating its flagship Platinum Partners Value Arbitrage Fund. In addition, the firm is also considering closing down its Platinum Partners Credit Opportunities Fund. In mid-June, one of the firm’s early backers and […]